Clinical trials for breast cancer
87 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT05774951
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier d'Argenteuil (Argenteuil), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Groupe Hospitalier Saint André (Bordeaux) (and 20 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT04862663
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
AstraZeneca
Phase 3
Breast cancer
#NCT04158362
HER2 Negative
HR Positive
Metastatic
Systemic Treatment-Naive
Chemotherapy
Hormone therapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Eugene Marquis (Rennes)
UNICANCER
Phase 3
Breast cancer
#NCT03820830
HER2 Negative
HR Positive
Localized
Surgery
Radiotherapy
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Antoine Lacassagne (Nice) (and 7 more...)
ETOP IBCSG Partners Foundation
Phase 3
Breast cancer
#NCT02089100
HR Positive
Metastatic
Surgery
Radiotherapy
Systemic Treatment-Naive
Surgery
Radiotherapy
Hormone therapy
Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Breast cancer
#NCT05646862
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
Targeted therapy
Hormone therapy
Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), IUCT Oncopôle (Toulouse) (and 2 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05232916
HER2 Positive
Localized
Locally Advanced
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital NOVO (Site de Pontoise) (Pontoise), Institut Godinot (Reims), Centre Antoine Lacassagne (Nice), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Centre Hospitalier Simone Veil de Beauvais (Beauvais)
Greenwich LifeSciences, Inc.
Phase 3
Breast cancer
#NCT06065748
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Hormone therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Eugene Marquis (Rennes), Centre Oscar Lambret (Lille), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon) (and 6 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05654623
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
Targeted therapy
Chemotherapy
Systemic Treatment-Naive
Centre Jean Perrin (Clermont Ferrand ), Hôpital Henri-Mondor AP-HP (Créteil), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 1 more...)
Pfizer
Phase 3
Breast cancer
#NCT05629585
HER2 Negative
HR Negative
Locally Advanced
Localized
Chemotherapy
Surgery
Chemotherapy
Surgery
BRCA 1/2
Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy) (and 8 more...)
AstraZeneca